<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04395586</url>
  </required_header>
  <id_info>
    <org_study_id>ACH—1</org_study_id>
    <nct_id>NCT04395586</nct_id>
  </id_info>
  <brief_title>Clinical Presentations, Microbiology, Antibiotic Resistance Patterns and Management Outcomes of Culture-proven Infection Among Adolescent and Adult in A Tertiary Hospital in Saudi Arabia</brief_title>
  <official_title>Clinical Presentations, Microbiology, Antibiotic Resistance Patterns and Management Outcomes of Culture-proven Infection Among Adolescent and Adult in A Tertiary Hospital in Saudi Arabia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aseer Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aseer Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The characteristics of patients as well as microbiologic profile of culture-proven infection
      will be studies in conjunction with clinical outcome within 28-days
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>28 days</time_frame>
    <description>All-cause and disease specific mortality</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Culture-proven Infection</condition>
  <arm_group>
    <arm_group_label>Culture-proven infected patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Culture</intervention_name>
    <description>Culture</description>
    <arm_group_label>Culture-proven infected patients</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Study will include a sample from blood, cerebrospinal fluid, intra-articular fluid,
      peritoneal fluid, pleural fluid, sputum, tissue (e.g., skin, bone, and cartilages), and
      urine.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Any individual aged ≥13 year old requested for him/her bacterial/fungal culture.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any individual aged ≥13 year old requested for him/her bacterial/fungal culture.

          -  Able to provide a written informed consent.

        Exclusion Criteria:

          -  Age &lt;13 years old.

          -  Unable/unwilling to provide a written informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Abdullah M Algarni, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aseer Central Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Abdullah M Algarni, MBBS</last_name>
    <phone>+966569967682</phone>
    <email>abaid1406@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ali Albashabshi, MBBS</last_name>
    <phone>+966504740409</phone>
    <email>albshabshe@yahoo.com</email>
  </overall_contact_backup>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 15, 2020</study_first_submitted>
  <study_first_submitted_qc>May 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 20, 2020</study_first_posted>
  <last_update_submitted>May 15, 2020</last_update_submitted>
  <last_update_submitted_qc>May 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aseer Central Hospital</investigator_affiliation>
    <investigator_full_name>Abdullah M. Algarni</investigator_full_name>
    <investigator_title>Family medicine senior registrar</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

